Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • official action...

    Tag: official action indicated

    You Searched For "official action indicated"
    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Sun Pharma: USFDA classifies Halol facility as Official Action Indicated

    Medical Dialogues Bureau30 March 2020 1:18 PM IST
    Mumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
    Aurobindo Pharma gets official action indicated classification from USFDA for its plant

    Aurobindo Pharma gets official action indicated classification from USFDA for its plant

    Meghna A Singhania30 Jan 2020 4:14 PM IST
    New Delhi: Aurobindo Pharma has announced that the US Food and Drug Administration (FDA) classified the inspection of the company's oral solids...
    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Medical Dialogues Bureau26 Nov 2019 9:30 AM IST
    In September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    Cadila Healthcare gets OAI letter from USFDA for Moraiya facility

    Cadila Healthcare gets OAI letter from USFDA for Moraiya facility

    Medical Dialogues Bureau8 Aug 2019 10:00 AM IST
    The company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
    Indoco Remedies: USFDA retains OAI status for Goa plant

    Indoco Remedies: USFDA retains OAI status for Goa plant

    Farhat Nasim25 April 2019 9:50 AM IST
    Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
    Lupin Somerset facility gets OAI letter from USFDA

    Lupin Somerset facility gets OAI letter from USFDA

    Farhat Nasim18 March 2019 9:25 AM IST
    "The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending...
    USFDA Caution: Lupin gets OAI letter for MP plant

    USFDA Caution: Lupin gets OAI letter for MP plant

    Medical Dialogues Bureau17 March 2019 9:45 AM IST
    Lupin has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Mandideep (Unit 1) facility...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok